Corneal Transplant Clinical Trial
— POVIADOfficial title:
Post Operative Visual Acuity for Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) and UT-DSAEK
| Verified date | September 2018 |
| Source | Centre Hospitalier Régional Metz-Thionville |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
To study the correlation between graft size in DSAEK (Descemet Stripping Automated Endothelial Keratoplasty) and UT (ultra thin)-DSAEK type corneal transplants to the visual acuity 6 months postoperatively.
| Status | Completed |
| Enrollment | 111 |
| Est. completion date | June 30, 2017 |
| Est. primary completion date | April 1, 2015 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | N/A and older |
| Eligibility |
Inclusion Criteria: - Patients who underwent DSAEK surgery - Patients in department of ophthalmology between february 2012 and june 2017 Exclusion Criteria: |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Centre Hospitalier Régional Metz-Thionville |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Postoperative visual acuity | postoperative visual acuity in logmar | Month 6 | |
| Secondary | Pachymetry | Measurement of the thickness of the cornea | Month 6 |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04521140 -
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery
|
Phase 4 | |
| Completed |
NCT01695655 -
Neovascularization Patterns in Corneal Graft Rejection
|
N/A |